Grandis, J R

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.

Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation

Cytokine Signaling Pathways and InteractionsHER2/EGFR in Cancer Research

Cited by 507

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., et al. (2003) · Proceedings of the National Academy of Sciences

Cytokine Signaling Pathways and InteractionsHead and Neck Cancer Studies

Cited by 340

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

Sen, M., Joyce, S., Panahandeh, M., Li, C., Thomas, S. M., Maxwell, J., Wang, L., Gooding, W. E., Johnson, D. E., & Grandis, J. R. (2012) · Clinical Cancer Research

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 158

STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines

Zhou, W., Grandis, J. R., & Wells, A. (2006) · British Journal of Cancer

Cytokine Signaling Pathways and InteractionsProstate Cancer Treatment and Research

Cited by 47

Critical analysis of the potential for targeting STAT3 in human malignancy

Grandis, J., & Peyser (2013) · OncoTargets and Therapy

Cytokine Signaling Pathways and InteractionsProtein Tyrosine Phosphatases

Cited by 24